Skip to Main Content

Author Details

Andrey Korshunov
Institute of Pathology, University Hospital Heidelberg
1985
365
98
Antoine Forget (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
35882450The first-in-class ERK inhibitor ulixertinib shows promising activity in mitogen-activated protein kinase (MAPK)-driven pediatric low-grade glioma models.Neuro Oncol2023
35882450The first-in-class ERK inhibitor ulixertinib shows promising activity in mitogen-activated protein kinase (MAPK)-driven pediatric low-grade glioma models.Neuro Oncol2023
36437415Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.Acta Neuropathol2023
37776353Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics.Acta Neuropathol2023
37093271Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypes.Acta Neuropathol2023
36715306Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroups.Neuro Oncol2023
36964296Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signature.NPJ Precis Oncol2023
36959034Corrigendum to 'Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry' [Eur J Cancer 180 (2023) 71-84].Eur J Cancer2023
36635768Comparison of transcriptome profiles between medulloblastoma primary and recurrent tumors uncovers novel variance effects in relapses.Acta Neuropathol Commun2023
37188167Clinical outcome following surgical resection and radiotherapy in adult patients with pleomorphic xanthoastrocytoma as defined by DNA methylation profiling.Neurooncol Pract2023
37379234Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome.Neuro Oncol2023
36933012Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions.Acta Neuropathol2023
36542877Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry.Eur J Cancer2023
36459208Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts.Acta Neuropathol2023
36786841Correction to: Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.Acta Neuropathol2023
37776353Genetical and epigenetical profiling identifies two subgroups of pineal parenchymal tumors of intermediate differentiation (PPTID) with distinct molecular, histological and clinical characteristics.Acta Neuropathol2023
36959034Corrigendum to 'Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry' [Eur J Cancer 180 (2023) 71-84].Eur J Cancer2023
37188167Clinical outcome following surgical resection and radiotherapy in adult patients with pleomorphic xanthoastrocytoma as defined by DNA methylation profiling.Neurooncol Pract2023
37379234Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome.Neuro Oncol2023
36964296Pediatric-type high-grade neuroepithelial tumors with CIC gene fusion share a common DNA methylation signature.NPJ Precis Oncol2023
37093271Transcriptome analysis stratifies second-generation non-WNT/non-SHH medulloblastoma subgroups into clinically tractable subtypes.Acta Neuropathol2023
36786841Correction to: Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.Acta Neuropathol2023
36715306Risk prediction in early childhood sonic hedgehog medulloblastoma treated with radiation-avoiding chemotherapy: Evidence for more than 2 subgroups.Neuro Oncol2023
36542877Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry.Eur J Cancer2023
36437415Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.Acta Neuropathol2023
36933012Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions.Acta Neuropathol2023
36459208Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohorts.Acta Neuropathol2023
36635768Comparison of transcriptome profiles between medulloblastoma primary and recurrent tumors uncovers novel variance effects in relapses.Acta Neuropathol Commun2023
34702771Clinically Tractable Outcome Prediction of Non-WNT/Non-SHH Medulloblastoma Based on TPD52 IHC in a Multicohort Study.Clin Cancer Res2022
35771282Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expression.Acta Neuropathol2022
35511748HIP1R and vimentin immunohistochemistry predict 1p/19q status in IDH-mutant glioma.Neuro Oncol2022
36070143Epigenetic profiling reveals a subset of pediatric-type glioneuronal tumors characterized by oncogenic gene fusions involving several targetable kinases.Acta Neuropathol2022
35475274Predictive modeling of resistance to SMO inhibition in a patient-derived orthotopic xenograft model of SHH medulloblastoma.Neurooncol Adv2022
34967922Oligosarcomas, IDH-mutant are distinct and aggressive.Acta Neuropathol2022
35012690Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survival.Acta Neuropathol Commun2022
34702771Clinically Tractable Outcome Prediction of Non-WNT/Non-SHH Medulloblastoma Based on TPD52 IHC in a Multicohort Study.Clin Cancer Res2022
35511748HIP1R and vimentin immunohistochemistry predict 1p/19q status in IDH-mutant glioma.Neuro Oncol2022
35771282Gene expression profiling of Group 3 medulloblastomas defines a clinically tractable stratification based on KIRREL2 expression.Acta Neuropathol2022
35475274Predictive modeling of resistance to SMO inhibition in a patient-derived orthotopic xenograft model of SHH medulloblastoma.Neurooncol Adv2022
36070143Epigenetic profiling reveals a subset of pediatric-type glioneuronal tumors characterized by oncogenic gene fusions involving several targetable kinases.Acta Neuropathol2022
35012690Pleomorphic xanthoastrocytoma is a heterogeneous entity with pTERT mutations prognosticating shorter survival.Acta Neuropathol Commun2022
34967922Oligosarcomas, IDH-mutant are distinct and aggressive.Acta Neuropathol2022
33479225Sarcoma classification by DNA methylation profiling.Nat Commun2021
34077956Therapeutic implications of improved molecular diagnostics for rare CNS embryonal tumor entities: results of an international, retrospective study.Neuro Oncol2021
33589929Integrated molecular analysis of adult sonic hedgehog (SHH)-activated medulloblastomas reveals two clinically relevant tumor subsets with VEGFA as potent prognostic indicator.Neuro Oncol2021
33585982Integrated molecular and clinical analysis of low-grade gliomas in children with neurofibromatosis type 1 (NF1).Acta Neuropathol2021
33479225Sarcoma classification by DNA methylation profiling.Nat Commun2021
33536079Molecular analysis of pediatric CNS-PNET revealed nosologic heterogeneity and potent diagnostic markers for CNS neuroblastoma with FOXR2-activation.Acta Neuropathol Commun2021
33629064Thrombospondin-1 mimetics are promising novel therapeutics for MYC-associated medulloblastoma.Neurooncol Adv2021
33580238Ultra high-risk PFA ependymoma is characterized by loss of chromosome 6q.Neuro Oncol2021
  • 1 - 50 of 730

Recommended Authors

Felix Behling
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year 2015
Number of shared co-authors 7
Calixto-Hope G Lucas
University of California San Francisco
Career Start Year 2014
Number of shared co-authors 22
Jennifer A Cotter
Children's Hospital Los Angeles
Career Start Year 2014
Number of shared co-authors 25
Kyle Juraschka
The Hospital for Sick Children, University of Toronto
Career Start Year 2014
Number of shared co-authors 59
Kentaro Ohara
Caryl and Israel Englander Institute for Precision Medicine.
Career Start Year 2012
Number of shared co-authors 0
Nitin R Wadhwani
Feinberg School of Medicine, Northwestern University
Career Start Year 2011
Number of shared co-authors 6
Jessica D Schulte
University of California
Career Start Year 2010
Number of shared co-authors 8
David R Raleigh
University of California san francisco
Career Start Year 2010
Number of shared co-authors 33
Cristiane M Ida
Mayo Clinic Foundation
Career Start Year 2007
Number of shared co-authors 11
Melitta Kitzwoegerer
Karl Landsteiner University of Health Sciences
Career Start Year 2007
Number of shared co-authors 3
David J Pisapia
NewYork-Presbyterian Hospital - Weill Cornell Medicine
Career Start Year 2004
Number of shared co-authors 7
Alessandro Raso
Giannina Gaslini Institute
Career Start Year 2003
Number of shared co-authors 33
Muh-Lii Liang
MacKay Memorial Hospital
Career Start Year 2003
Number of shared co-authors 21
Daniel Martinez
Perelman School of Medicine at the University of Pennsylvania
Career Start Year 2002
Number of shared co-authors 24
Ga??lle Pierron
Institut Curie Hospital
Career Start Year 2001
Number of shared co-authors 33
Ho Jun Seol
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2001
Number of shared co-authors 6
Naoki Shinojima
Kumamoto University Hospital
Career Start Year 2000
Number of shared co-authors 6
Chul-Kee Park
College of Medicine, Seoul National University
Career Start Year 2000
Number of shared co-authors 13
Ghazaleh Tabatabai
University Hospital Tubingen, Eberhard-Karls-University Tubingen
Career Start Year 1998
Number of shared co-authors 34
Anat Stemmer-Rachamimov
Massachusetts General Hospital
Career Start Year 1997
Number of shared co-authors 24
Do-Hyun Nam
Samsung Medical Center, Sungkyunkwan University School
Career Start Year 1996
Number of shared co-authors 31
Vinay K Puduvalli
The University of Texas MD Anderson Cancer Center
Career Start Year 1996
Number of shared co-authors 15
Erik P Sulman
NYU Grossman School of Medicine
Career Start Year 1995
Number of shared co-authors 40
Yeon-Lim Suh
Samsung Medical Center, Sungkyunkwan University College of Medicine
Career Start Year 1994
Number of shared co-authors 0
Gudrun Schleiermacher
Institut Curie
Career Start Year 1994
Number of shared co-authors 32
Johannes A Hainfellner
Medical University of Vienna
Career Start Year 1992
Number of shared co-authors 23
Howard A Fine
Meyer Cancer Center
Career Start Year 1990
Number of shared co-authors 12
Alexander O Vortmeyer
Indiana University School of Medicine
Career Start Year 1988
Number of shared co-authors 5
Motoo Nagane
Kyorin University Faculty of Medicine
Career Start Year 1988
Number of shared co-authors 9
Gaetano Finocchiaro
IRCCS San Raffaele Scientific Institute
Career Start Year 1983
Number of shared co-authors 102

Collaborators

Stefan M Pfister
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 233
David T W Jones
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 145
Marcel Kool
Hopp Children's Cancer Center (KiTZ)
Co-authored papers 133
Andreas von Deimling
Co-authored papers 125
Peter Lichter
German Cancer Research Center (DKFZ)
Co-authored papers 84
Michael D Taylor
The Hospital for Sick Children
Co-authored papers 75
Felix Sahm
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 73
Paul A Northcott
St Jude Children's Research Hospital
Co-authored papers 69
Marina Ryzhova
N.N. Burdenko Neurosurgical Institute
Co-authored papers 63
Marc Remke
and Clinical Immunology, Heinrich Heine University, University Hospital Dusseldorf
Co-authored papers 62
Till Milde
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 59
Olaf Witt
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 58
Dominik Sturm
Hopp Children's Cancer Center Heidelberg (KiTZ)
Co-authored papers 56
David Capper
Charite University Medicine Berlin
Co-authored papers 53
Hendrik Witt
Co-authored papers 48
Martin Sill
Co-authored papers 47
Nada Jabado
McGill University Health Centre (MUHC), Montreal Children's Hospital (MCH)
Co-authored papers 46
Christel Herold-Mende
Co-authored papers 38
Guido Reifenberger
Heinrich Heine University
Co-authored papers 38
Ulrich Sch??ller
University Medical Center Hamburg-Eppendorf
Co-authored papers 37
Andreas E Kulozik
Co-authored papers 37
Stefan Rutkowski
University Medical Center Hamburg-Eppendorf
Co-authored papers 37
Torsten Pietsch
Co-authored papers 35
Vijay Ramaswamy
Hospital for Sick Children
Co-authored papers 33
Kristian W Pajtler
Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg University
Co-authored papers 31
David W Ellison
St. Jude Children's Research Hospital
Co-authored papers 28
Cynthia Hawkins
The Hospital for Sick Children
Co-authored papers 27
Marc Zapatka
Co-authored papers 26
Andreas Unterberg
Co-authored papers 26
Uri Tabori
Co-authored papers 25
Release 1.2